4Thomas ED, Strob R, Clift RA, et al. Bone marrow transplantation ( second of the two part) [ J ]. N Engl J Med, 1975,292 : 895 - 902.
5Santos GW,Tutschka PJ, Brookmeyer R, et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide [ J]. N Engl J Med, 1983,309 (22) : 1347 - 1353.
6Tutschka PJ, Copelan EA, Klein JP, Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen[J]. Blood,1987,70(5) :1382 - 1388.
7Bhatia M, Wang JCY, Kapp U, et al. [J]. Proc Natl Acad Sci USA,1997,94(10): 5320-5325.
8Link H, Arseniev L, Bahra O, et al. [J]. Blood, 1996, 87(11): 4903-4909.
5Sarzotti-Kelsoe M, Win C M, Parrott R E, et al. Thymic output, T- cell diversity, and T-cell function in long-term human SCID chimeras [J]. Blood, 2009, 114(7) : 1445 -1453.
6Zanjani E D, Almeida-Porada G, Livingston A G, et al. Human hone marrow CD34 - cells engraft in vivo and undergo multilineage expres- sion that includes giving rise to CD34 ^+ cells [ J ]. Exp Hematol, 1998, 26(4) : 353 -360.
7Ziegler B L, Vahieri M, Porada G A, et al. KDR receptor: a key marker defining hematopoietic stem cells [ J ]. Science, 1999, 285 (5433) :1553 - 1558.
8Watanabe Y, Takahashi T, Okajima A, et al. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice ( hu-HSC NOG mice) [ J ]. Int Immunol, 2009, 21(7) : 843 -858.
9Giassi L J, Pearson T, Shultz L D, et al. Expanded CD34 ^+ human umbilical cord blood cells generate multiple tymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice[ J]. Exp Biol Med (May- wood), 2008, 233(8): 997-1012.
10Hogan C J, Shpall E J, McNulty O, et al. Engraftment and development of human CD34( + )-enriched cells from umbilical cord blood in NOD/LtSz-scicL/scid mice[ J]. Blood, 1997, 90( 1 ) :85 -96.
